PCR130 Factors Associated With Adjuvant Treatment Options in Resected Stage III Melanoma, From a Patient and Physician Perspective: Preference Assessment Using the Discrete Choice Experiment Method (Pamela Study)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2569
https://www.valueinhealthjournal.com/article/S1098-3015(23)05699-1/fulltext
Title :
PCR130 Factors Associated With Adjuvant Treatment Options in Resected Stage III Melanoma, From a Patient and Physician Perspective: Preference Assessment Using the Discrete Choice Experiment Method (Pamela Study)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05699-1&doi=10.1016/j.jval.2023.09.2569
First page :
Section Title :
Open access? :
No
Section Order :
11910